Inventor · disambiguated record
Dan Zhou
Also filed as: ZHOU DAN
15 granted patents·11 pending applications·369 citations·filing 2000–2024
94Inventor score
Files withSYNTA PHARMACEUTICALS CORP13CHIMMANAMADA DINESH U2HAPLNSCIENCE INC2YING WEIWEN2LEE CHI-WAN1
Top patents by PatentIndex Score
26 records- 0197US8053456B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Nov 8, 2011·58 cites·12 claims
- 0296US8415377B2Triazole compounds that modulate HSP90 activitySUN LIJUN·Filed 2011·Granted Apr 9, 2013·40 cites·19 claims
- 0396US8318790B2Triazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2007·Granted Nov 27, 2012·49 cites·68 claims
- 0495US8835464B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Sep 16, 2014·32 cites·17 claims
- 0595US8628752B2Methods of identifying HSP90 inhibitors with less ocular toxicitySYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Jan 14, 2014·15 cites·8 claims
- 0694US8329736B2Triazole compounds that modulate HSP90 activityCHIMMANAMADA DINESH U·Filed 2012·Granted Dec 11, 2012·27 cites·14 claims
- 0794US8183384B2Triazole compounds that modulate HSP90 activityCHIMMANAMADA DINESH U·Filed 2007·Granted May 22, 2012·26 cites·16 claims
- 0890US6384032B1Inhibitors of IL-12 productionSHIONOGI BIORES CORP·Filed 2000·Granted May 7, 2002·63 cites·36 claims
- 0988US9206162B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2015·Granted Dec 8, 2015·6 cites·3 claims
- 1088US8927548B2Triazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2012·Granted Jan 6, 2015·10 cites·9 claims
- 1187US9006277B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2014·Granted Apr 14, 2015·7 cites·8 claims
- 1286US8524712B2Triazinone and diazinone derivatives useful as HSP90 inhibitorsLEE CHI-WAN·Filed 2008·Granted Sep 3, 2013·15 cites·8 claims
- 1386US7763658B2Treatment for cancersSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Jul 27, 2010·21 cites·6 claims
- 1476US12252601B1Preparation method for bio-based nucleating agent for poly(ethylene furandicarboxylate) and application thereofUNIV TAIYUAN SCIENCE & TECH·Filed 2024·Granted Mar 18, 2025·0 cites·3 claims
- 1562US2019144398A1Method for treating inflammatory disordersSYNTA PHARMACEUTICALS CORP·Filed 2019·Application pending·0 cites
- 1662US2010280032A1Method for treating inflammatory disordersSYNTA PHARMACEUTICALS CORP·Filed 2007·Application pending·0 cites
- 1759US2014141511A1Method for treating inflammatory disordersZHOU DAN·Filed 2013·Application pending·0 cites
- 1859US2015183771A1Triazole compounds that modulate hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 1958US2014127740A1Methods of identifying hsp90 inhibitors with less ocular toxicitySYNTA PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 2057US2017320837A1Method for treating inflammatory disordersSYNTA PHARMACEUTICALS CORP·Filed 2017·Application pending·0 cites
- 2153US2013072461A1Triazole compounds that modulate hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 2251US12268728B2Composition for preventing or treating pulmonary diseases comprising hyaluronan and proteoglycan link protein 1HAPLNSCIENCE INC·Filed 2021·Granted Apr 8, 2025·0 cites·8 claims
- 2349US2013345219A1Triazinone and diazinone derivatives useful as hsp90 inhibitorsSYNTA PHARMACEUTICALS CORP·Filed 2013·Application pending·0 cites
- 2447US2005203119A1Dihydropyridine compounds for treating or preventing metabolic disordersFiled 2004·Application pending·0 cites
- 2543US2022202899A1Composition for prevention or treatment of hair loss including hapln1HAPLNSCIENCE INC·Filed 2020·Application pending·0 cites
- 2632US2012231542A1Biologically Active Human Umbilical Cord Blood Cell Extract Compounds and MethodsWOODS ERIK J·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dan Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →